Lorrain Daniel S.
Chief Scientific Officer
Lorrain Daniel S. has filed 12 SEC Form 4 filings (27 transaction rows) across 1 company, with disclosures dating back to 2025. 12 of those filings fall inside the rolling window. Most recent filing: Jul 10, 2026.
On the most recent filing, Lorrain Daniel S. is listed as Chief Scientific Officer at Contineum Therapeutics, Inc. Inside the rolling window, Lorrain Daniel S. reported no open-market purchases and 15 open-market sales totaling $1.1M in CTNM. The largest disclosed transaction in the window is a sale of 28,826 CTNM shares on Jun 30, 2026, worth $462K.
Companies traded
Other insiders at CTNM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CTNM | Chief Scientific Officer | Sale | 1,015 | $16K | Jul 10 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 25 | $400 | Jul 10 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 28,826 | $462K | Jul 2 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 8,353 | $132K | Jul 2 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $55K | Jun 1 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $55K | May 1 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $56K | Apr 6 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $63K | Mar 2 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,300 | $69K | Feb 26 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 3,824 | $61K | Feb 26 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 100 | $2K | Feb 20 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 400 | $6K | Feb 13 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $62K | Feb 5 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $44K | Jan 6 | SEC ↗ | |
| CTNM | Chief Scientific Officer | Sale | 4,170 | $51K | Dec 30 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 filings has Lorrain Daniel S. made?
Lorrain Daniel S. has filed 12 SEC Form 4 filings (27 transaction rows) across 1 company since 2025.
Which companies does Lorrain Daniel S. trade?
Lorrain Daniel S. has filed SEC Form 4 disclosures for 1 company, including CTNM.
When was Lorrain Daniel S.'s most recent SEC Form 4 filing?
Lorrain Daniel S.'s most recent SEC Form 4 filing on Tracefour is dated Jul 10, 2026.
What is Lorrain Daniel S.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Lorrain Daniel S. is listed as Chief Scientific Officer.
What is Lorrain Daniel S.'s total buy and sell value in the current window?
Inside the rolling retention window, Lorrain Daniel S. bought $0 and sold $1.1M based on SEC Form 4 filings.
What was Lorrain Daniel S.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 28,826 CTNM shares on 2026-06-30, worth $462K, per SEC Form 4 filings.